A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis

Area of Science:

• Oncology
• Molecular Biology
• Developmental Biology

Background:

• Wnt signaling is crucial for embryonic development.
• Aberrations in Wnt signaling are linked to colorectal cancer.
• The role of specific Wnt pathway components in metastasis is under investigation.

Purpose of the Study:

• To investigate the role of Frizzled2 (Fzd2) and Wnt5a/b in cancer metastasis.
• To elucidate the molecular mechanisms by which Fzd2 influences epithelial-mesenchymal transition (EMT) and cell migration.
• To evaluate the therapeutic potential of targeting Fzd2 in preclinical cancer models.

Main Methods:

• Analysis of Fzd2 and Wnt5a/b expression in cancer cell lines and tumors.
• Pharmacologic and genetic manipulation to study Fzd2 function.
• Assessment of EMT markers, cell migration, and invasion.
• Development and testing of an anti-Fzd2 antibody in xenograft models.
• Gene expression profiling to identify a predictive signature.

Main Results:

• Fzd2 and Wnt5a/b are upregulated in metastatic cancer cell lines and high-grade tumors.
• Fzd2 expression correlates with EMT markers.
• Fzd2 promotes EMT and cell migration via a noncanonical Fyn/Stat3 pathway.
• A Fzd2-regulated gene signature predicts patient metastasis and survival.
• An anti-Fzd2 antibody inhibited tumor growth, metastasis, migration, and invasion in vivo.

Conclusions:

• Fzd2 and Wnt5a/b play a significant role in driving cancer metastasis.
• The Fzd2/Fyn/Stat3 pathway represents a novel mechanism for EMT and cell migration.
• Targeting Fzd2 with antibodies offers a potential therapeutic strategy for metastatic cancers.
• This pathway may benefit patients with high Fzd2 and Wnt5a/b expressing tumors.